1. Home
  2. ACLX vs DAVE Comparison

ACLX vs DAVE Comparison

Compare ACLX & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACLX
  • DAVE
  • Stock Information
  • Founded
  • ACLX 2015
  • DAVE 2017
  • Country
  • ACLX United States
  • DAVE United States
  • Employees
  • ACLX 163
  • DAVE 274
  • Industry
  • ACLX Biotechnology: Pharmaceutical Preparations
  • DAVE Retail: Computer Software & Peripheral Equipment
  • Sector
  • ACLX Health Care
  • DAVE Technology
  • Exchange
  • ACLX Nasdaq
  • DAVE Nasdaq
  • Market Cap
  • ACLX 3.5B
  • DAVE 2.9B
  • IPO Year
  • ACLX 2022
  • DAVE N/A
  • Fundamental
  • Price
  • ACLX $63.00
  • DAVE $211.00
  • Analyst Decision
  • ACLX Strong Buy
  • DAVE Strong Buy
  • Analyst Count
  • ACLX 14
  • DAVE 6
  • Target Price
  • ACLX $111.42
  • DAVE $212.33
  • AVG Volume (30 Days)
  • ACLX 631.2K
  • DAVE 445.7K
  • Earning Date
  • ACLX 08-07-2025
  • DAVE 08-04-2025
  • Dividend Yield
  • ACLX N/A
  • DAVE N/A
  • EPS Growth
  • ACLX N/A
  • DAVE N/A
  • EPS
  • ACLX N/A
  • DAVE 3.70
  • Revenue
  • ACLX $76,809,000.00
  • DAVE $381,425,000.00
  • Revenue This Year
  • ACLX N/A
  • DAVE $37.77
  • Revenue Next Year
  • ACLX $112.68
  • DAVE $17.77
  • P/E Ratio
  • ACLX N/A
  • DAVE $57.03
  • Revenue Growth
  • ACLX N/A
  • DAVE 39.31
  • 52 Week Low
  • ACLX $47.86
  • DAVE $28.31
  • 52 Week High
  • ACLX $107.37
  • DAVE $243.25
  • Technical
  • Relative Strength Index (RSI)
  • ACLX 47.45
  • DAVE 57.19
  • Support Level
  • ACLX $64.77
  • DAVE $186.20
  • Resistance Level
  • ACLX $66.73
  • DAVE $243.25
  • Average True Range (ATR)
  • ACLX 2.89
  • DAVE 13.35
  • MACD
  • ACLX -0.35
  • DAVE -5.24
  • Stochastic Oscillator
  • ACLX 25.18
  • DAVE 43.47

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

About DAVE Dave Inc.

Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.

Share on Social Networks: